Unternehmen Synaptogenix, Inc. Other OTC
Aktien
A2QKZF
US87167T1025
SNPX
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01.01.18 |
Daniel Alkon
PSD | President | 81 | 07.12.20 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 01.10.13 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01.01.18 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 14.11.16 |
Joshua Silverman
CHM | Chairman | 53 | 04.08.16 |
Director/Board Member | 50 | 13.12.18 | |
William Singer
BRD | Director/Board Member | 82 | 23.08.13 |
Daniel Alkon
PSD | President | 81 | 07.12.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 233 230 | 1 206 807 ( 97,86 %) | 0 | 97,86 % |
Aktie B | 0 | 3 000 | 0 | 0 |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+67.53% | 63.85 Mrd. | |
-0.77% | 41.83 Mrd. | |
+45.66% | 40.65 Mrd. | |
-10.72% | 27.12 Mrd. | |
+13.30% | 26.52 Mrd. | |
-22.79% | 18.69 Mrd. | |
+4.70% | 12.73 Mrd. | |
+24.10% | 12.11 Mrd. | |
+27.41% | 12.07 Mrd. |